• 2011

Company Description

INTICA Biomedical develops a combined product that consists of targeted therapy and companion diagnostics for triple negative breast cancer.

INTICA Biomedical, Inc. develops a combination product consisting of Targeted Therapy & Companion Diagnostic for Triple Negative Breast Cancer (TNBC). The novel drug target DEspR and its associated pathway represent true breakthrough discoveries. The NCI and the Susan G Komen Foundation are actively supporting the company's development program in TNBC.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2011
  • Founders:

    Nelson Ruiz Opazo
  • Company Website:

  • Company E-mail:

  • Company Address:

    23 Blueberry Lane
    Lexington, MA
    United States
  • CEO:

    • Nelson Ruiz Opazo
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits